Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.

Published in:

2020

By:

• Lerebours, Florence;
• Pulido, Marina;
• Fourme, Emmanuelle;
• Debled, Marc;
• Becette, Véronique;
• Bonnefoi, Hervé;
• Rivera, Sofia;
• MacGrogan, Gaetan;
• Mouret-Reynier, Marie-Ange;
• de Lara, Christine Tunon;
• Pierga, Jean-Yves;
• Breton-Callu, Christel;
• Venat-Bouvet, Laurence;
• Mathoulin-Pélissier, Simone;
• de la Motte rouge, Thibault;
• Dalenc, Florence;
• Sigal, Brigitte;
• Bachelot, Thomas;
• Lemonnier, Jérôme;
• Quenel-Tueux, Nathalie

Publication type:

journal article